Besivance is a Ophthalmic Suspension in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Besifloxacin.
| Product ID | 50090-1241_354afd39-0900-4c16-be1a-e47978ab280c | 
| NDC | 50090-1241 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Besivance | 
| Generic Name | Besifloxacin | 
| Dosage Form | Suspension | 
| Route of Administration | OPHTHALMIC | 
| Marketing Start Date | 2009-05-28 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA022308 | 
| Labeler Name | A-S Medication Solutions | 
| Substance Name | BESIFLOXACIN | 
| Active Ingredient Strength | 6 mg/mL | 
| Pharm Classes | Quinolone Antimicrobial [EPC],Quinolones [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2014-11-28 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA022308 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2014-11-28 | 
| Marketing End Date | 2019-12-31 | 
| Ingredient | Strength | 
|---|---|
| BESIFLOXACIN | 6 mg/mL | 
| SPL SET ID: | b111b1ab-10b0-4378-8aef-e51d5274306c | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 24208-446 | Besivance | Besifloxacin | 
| 50090-1241 | Besivance | Besifloxacin | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  BESIVANCE  77632895  3796795 Live/Registered | BAUSCH & LOMB INCORPORATED 2008-12-15 |